Informationen:
Fehler:
ID
26941
Beschreibung
XERAD: A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Breast Cancer With Newly Diagnosed Brain Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00977379
Link
https://clinicaltrials.gov/show/NCT00977379
Stichworte
Versionen (1)
- 28.10.17 28.10.17 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
28. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00977379
Eligibility Breast Cancer NCT00977379
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00977379
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender | Age
Item
women >/= 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Breast Carcinoma | HER2/Neu Status Known | Hormone Receptor Status Known
Item
histologically confirmed breast cancer with known her2 and hormone status
boolean
C0678222 (UMLS CUI [1])
C1512413 (UMLS CUI [2,1])
C0205309 (UMLS CUI [2,2])
C0019929 (UMLS CUI [3,1])
C0449438 (UMLS CUI [3,2])
C0205309 (UMLS CUI [3,3])
C1512413 (UMLS CUI [2,1])
C0205309 (UMLS CUI [2,2])
C0019929 (UMLS CUI [3,1])
C0449438 (UMLS CUI [3,2])
C0205309 (UMLS CUI [3,3])
CNS metastases | Measurable lesion Quantity
Item
newly diagnosed cns metastasis with at least one measurable (>/=0.5cm) lesion
boolean
C0686377 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Patient Ineligible | Refused Surgery | Radiosurgery Refused
Item
patient not eligible or refusing surgery or stereotactic radiosurgery
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C0749192 (UMLS CUI [2])
C0085203 (UMLS CUI [3,1])
C1705116 (UMLS CUI [3,2])
C1512714 (UMLS CUI [1,2])
C0749192 (UMLS CUI [2])
C0085203 (UMLS CUI [3,1])
C1705116 (UMLS CUI [3,2])
ECOG performance status
Item
eocg performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Therapeutic procedure Metastatic malignant neoplasm to brain
Item
prior treatment of brain metastases
boolean
C0087111 (UMLS CUI [1,1])
C0220650 (UMLS CUI [1,2])
C0220650 (UMLS CUI [1,2])
Disease Progression | Metastatic malignant neoplasm to brain | capecitabine
Item
prior disease progression or appearance of brain metastases while on treatment with capecitabine
boolean
C0242656 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0671970 (UMLS CUI [3])
C0220650 (UMLS CUI [2])
C0671970 (UMLS CUI [3])
Leptomeningeal Neoplasms
Item
leptomeningeal disease
boolean
C0751297 (UMLS CUI [1])
Medical contraindication Therapeutic radiology procedure | Medical contraindication MRI | Medical contraindication capecitabine
Item
known contra-indication to radiotherapy or mri or capecitabine
boolean
C1301624 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0671970 (UMLS CUI [3,2])
C1522449 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0671970 (UMLS CUI [3,2])